| Issue Date | Title | Author(s) |
| 2022 | 3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies. | Shi, H; Rath, EM; Lin, RCY; Sarun, KH; Clarke, CJ; McCaughan, BC; Ke, H; Linton, A; Lee, K; Klebe, S; Maitz, J; Song, K; Wang, Y; Kao, S; Cheng, YY |
| 2018-02-01 | Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma | Johnson, TG; Schelch, K; Cheng, YY; Williams, M; Sarun, KH; Kirschner, MB; Kao, S; Linton, A; Klebe, S; McCaughan, BC; Lin, RCY; Pirker, C; Berger, W; Lasham, A; van Zandwijk, N; Reid, G |
| 2022-01 | GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol) | Conduit, C; Mak, B; Qu, W; Di Lulio, J; Burder, R; Bressel, M; Cusick, T; Dhillon, HM; De Abreu Lourenço, R; Underhill, C; Torres, J; Crumbaker, M; Honeyball, F; Linton, A; Allen, R; Davis, ID; Clark, SJ |
| 2023-02-21 | Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study. | Lee, J; Currow, D; Lovell, M; Phillips, JL; McLachlan, A; Ritchie, M; Brown, L; Fazekas, B; Aggarwal, R; Seah, D; Sheehan, C; Chye, R; Noble, B; McCaffrey, N; Aggarwal, G; George, R; Kow, M; Ayoub, C; Linton, A; Sanderson, C; Mittal, D; Rao, A; Prael, G; Urban, K; Vandersman, P; Agar, M |
| 2017-09-01 | Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma | Kao, SC; Cheng, YY; Williams, M; Kirschner, MB; Madore, J; Lum, T; Sarun, KH; Linton, A; McCaughan, B; Klebe, S; van Zandwijk, N; Scolyer, RA; Boyer, MJ; Cooper, WA; Reid, G |
